You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Legacy Pharma Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for LEGACY PHARMA, and what generic and branded alternatives to LEGACY PHARMA drugs are available?

LEGACY PHARMA has seven approved drugs.



Summary for Legacy Pharma
US Patents:0
Tradenames:6
Ingredients:5
NDAs:7

Drugs and US Patents for Legacy Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Legacy Pharma BETAPACE AF sotalol hydrochloride TABLET;ORAL 021151-001 Feb 22, 2000 AB RX Yes No ⤷  Sign Up ⤷  Sign Up
Legacy Pharma Usa ZANAFLEX tizanidine hydrochloride CAPSULE;ORAL 021447-003 Aug 29, 2002 AB RX Yes Yes ⤷  Sign Up ⤷  Sign Up
Legacy Pharma Usa ZANAFLEX tizanidine hydrochloride TABLET;ORAL 020397-002 Feb 4, 2000 DISCN Yes No ⤷  Sign Up ⤷  Sign Up
Legacy Pharma BETAPACE sotalol hydrochloride TABLET;ORAL 019865-001 Oct 30, 1992 AB RX Yes No ⤷  Sign Up ⤷  Sign Up
Legacy Pharma Usa ZANAFLEX tizanidine hydrochloride CAPSULE;ORAL 021447-002 Aug 29, 2002 AB RX Yes No ⤷  Sign Up ⤷  Sign Up
Legacy Pharma BETAPACE AF sotalol hydrochloride TABLET;ORAL 021151-002 Feb 22, 2000 AB RX Yes No ⤷  Sign Up ⤷  Sign Up
Legacy Pharma BETAPACE AF sotalol hydrochloride TABLET;ORAL 021151-006 Apr 2, 2003 DISCN No No ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Legacy Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Legacy Pharma Usa ZANAFLEX tizanidine hydrochloride CAPSULE;ORAL 021447-001 Aug 29, 2002 6,455,557 ⤷  Sign Up
Legacy Pharma Usa ZANAFLEX tizanidine hydrochloride CAPSULE;ORAL 021447-003 Aug 29, 2002 6,455,557 ⤷  Sign Up
Legacy Pharma Usa ZANAFLEX tizanidine hydrochloride CAPSULE;ORAL 021447-002 Aug 29, 2002 6,455,557 ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Paragraph IV (Patent) Challenges for LEGACY PHARMA drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Capsules 2 mg, 4 mg and 6 mg ➤ Subscribe 2007-08-10
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.